{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:24:32Z","timestamp":1776119072695,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":290,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2001,3,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1. In the present study, we examined whether KRH\u2010594, a new angiotensin AT<jats:sub>1<\/jats:sub> receptor antagonist, would stop the progression of renal failure and end\u2010organ damage and improve the survival rate in salt\u2010loaded stroke\u2010prone spontaneously hypertensive rats (SHRSP\/Izm).<\/jats:p><jats:p>2. Oral administration of KRH\u2010594 (3 and 10 mg\/kg per day) for 11 weeks significantly reduced systolic blood pressure, urinary total protein, blood urea nitrogen, serum creatinine and urinary <jats:italic>N<\/jats:italic>\u2010acetyl glucosaminidase and increased creatinine clearance in SHRSP\/Izm.<\/jats:p><jats:p>3. In a histological study, KRH\u2010594 (3 and 10 mg\/kg per day) significantly improved the glomerulosclerosis, basophilic change and hyalin cast of tubules, proliferation of afferent arterioles and interlobular artery wall scores of the kidney and the cardiac fibrosis scores of the heart in SHRSP\/Izm. KRH\u2010594 (3 and 10 mg\/kg per day) also significantly inhibited cardiac hypertrophy.<\/jats:p><jats:p>4. KRH\u2010594 (3 and 10 mg\/kg per day) prevented death in SHRSP\/Izm during the examination period.<\/jats:p><jats:p>5. These results suggest that KRH\u2010594 improves hypertensive complications, such as renal failure, cardiac hypertrophy and thickening of the artery wall, and prevents death in salt\u2010loaded SHRSP\/Izm.<\/jats:p>","DOI":"10.1046\/j.1440-1681.2001.03430.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T11:09:36Z","timestamp":1047380976000},"page":"206-211","source":"Crossref","is-referenced-by-count":9,"title":["KRH\u2010594, A New Angiotensin At<sub>1<\/sub> Receptor Antagonist, Prevents End\u2010Organ Damage In Stroke\u2010Prone Spontaneously Hypertensive\/Izm Rats"],"prefix":"10.1111","volume":"28","author":[{"given":"Yoichi","family":"Inada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuo","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199603000-00016"},{"key":"e_1_2_7_3_2","unstructured":"RaijL.Role of hypertension in progressive glomerular injury in glomerulonephritis.Hypertension1986;8(Suppl. I): I\u201030\u20133."},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(80)90205-1"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197203022860901"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1997.tb02699.x"},{"key":"e_1_2_7_7_2","first-page":"948","article-title":"Chronic carvedilol reduces mortality and renal damage in hypertensive stroke\u2010prone rats.","volume":"279","author":"Barone FC","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199209000-00003"},{"key":"e_1_2_7_9_2","unstructured":"KatohY KomuroI ShibasakiY YamaguchiH&YazakiY.Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes.Circulation1989;80(Suppl. II): II\u2010450 (Abstract)."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.404"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0930401"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969709083206"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","unstructured":"LessDR SquireIB&ReidJL.The clinical pharmacology of ACE inhibitors: Evidence for clinically relevant differences?Clin. Exp. Pharmacol. Physiol.1992;19(Suppl. 19): 49\u201353.","DOI":"10.1111\/j.1440-1681.1992.tb02810.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","unstructured":"InadaY NakaneT TazawaS&ChibaS.Binding property of KRH\u2010594 a new AT1receptor antagonist to cloned angiotensin receptors.Jpn. J. Pharmacol.1999;79(Suppl. I): 135P (Abstract).","DOI":"10.1016\/S0021-5198(19)34552-4"},{"key":"e_1_2_7_15_2","first-page":"13","article-title":"Effects of a new AT1 receptor antagonist KRH\u2010594 on several types of experimental hypertension.","volume":"49","author":"Inada Y","year":"1999","journal-title":"Drug Res."},{"key":"e_1_2_7_16_2","first-page":"1099","article-title":"Effects of the new angiotensin receptor antagonist dipotassium (Z)\u20102\u2010[[5\u2010ethyl\u20103\u2010[2\u2032\u2010(1H\u2010tetrazol\u20105\u2010yl) biphenyl\u20104\u2010yl]methyl\u20101,3,4\u2010thiadiazoline\u20102\u2010ylidene]aminocarbonyl]\u20101\u2010cyclopentenecarboxylate on experimental cardiac hypertrophy and acute left ventricular failure.","volume":"47","author":"Murakami M","year":"1997","journal-title":"Drug Res."},{"key":"e_1_2_7_17_2","first-page":"898","article-title":"Angiotensin II type 1 receptor blockade prevents up\u2010regulation of angiotensin II type 1A receptors and neointimal formation in balloon\u2010injured rat artery.","volume":"288","author":"Tazawa S","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","unstructured":"InadaY MurakamiM TazawaS&AkahaneM.KRH\u2010594 a new angiotensin AT1receptor antagonist ameliorates nephropathy and hyperlipidaemia in diabetic spontaneously hypertensive rats.Clin. Exp. Pharmacol. Physiol.2000;27: 270\u20136.","DOI":"10.1046\/j.1440-1681.2000.03235.x"},{"key":"e_1_2_7_19_2","first-page":"327","article-title":"Prevention of stroke with perindopril treatment in stroke\u2010prone spontaneously hypertensive rats.","volume":"20","author":"Wang H","year":"1997","journal-title":"Clin. Invest. Med."},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.66.231"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.113"},{"key":"e_1_2_7_22_2","first-page":"F41","article-title":"Losartan in patients with renal insufficiency.","volume":"11","author":"De Zeeuw D","year":"1995","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199006000-00010"},{"key":"e_1_2_7_24_2","unstructured":"FyhrquistF Mets\u00e4rinneK&TikkanenI.Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.J. Hum. Hypertens.1995;9(Suppl. 5): S19\u201324."},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)01048-0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.71.39"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.232"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajh\/4.8.680","article-title":"Therapeutic benefit of captopril in salt\u2010loaded stroke\u2010prone spontaneously hypertensive rats is independent of hypotensive effects.","volume":"4","author":"Stier CT","year":"1991","journal-title":"Am. J. Hypertens."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969109042114"},{"key":"e_1_2_7_30_2","first-page":"948","article-title":"Chronic carvedilol reduces mortality and renal damage in hypertensive stroke\u2010prone rats.","volume":"279","author":"Barone FC","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_31_2","first-page":"269","article-title":"Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats.","volume":"228","author":"Suzuki M","year":"1993","journal-title":"Eur. J. Pharmacol."}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1681.2001.03430.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1681.2001.03430.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:19:01Z","timestamp":1697537941000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1681.2001.03430.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3,5]]}},"alternative-id":["10.1046\/j.1440-1681.2001.03430.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1681.2001.03430.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,5]]}}}